Skip to content

CHEMBIO DIAGNOSTICS, INC.

Delisted

CIK 1092662fmd_106B9NSQ6CC3TKVX0ZKC8BWB46Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2022, 51 periods

Latest annual · FY2022

Millions
Total revenues
50
Gross profit
11
Operating income
(24)
Net income
(23)
Free cash flow
(33)

Latest quarter · Q4 FY2022

Millions
Total revenues
10
Gross profit
5
Operating income
(3)
Net income
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+12.8%
Revenue, 5 yearsFY2017 to FY2022
+14.5%
Net income, 5 yearsFY2017 to FY2022
n/m

CHEMBIO DIAGNOSTICS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$49.5 million$47.8 million+3.6%10-K 2023-03-29 · proof
Gross profit$10.9 million$13.3 million-17.9%10-K 2023-03-29 · proof
Operating income-$23.6 million-$31.1 million10-K 2023-03-29 · proof
Net income-$23.3 million-$33.9 million10-K 2023-03-29 · proof
Cash from operating activities-$12.7 million-$30.9 million10-K 2023-03-29 · proof
Total assets$62.6 million$73.3 million-14.5%10-K 2023-03-29 · proof
Total liabilities$44.8 million$39 million+14.9%10-K 2023-03-29 · proof
Cash and cash equivalents$18.2 million$28.8 million-36.8%10-K 2023-03-29 · proof
What was CHEMBIO DIAGNOSTICS, INC.'s revenue in fiscal 2022?
CHEMBIO DIAGNOSTICS, INC. reported revenue of $49.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $47.8 million the year before (+3.6%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What was CHEMBIO DIAGNOSTICS, INC.'s gross profit in fiscal 2022?
CHEMBIO DIAGNOSTICS, INC. reported gross profit of $10.9 million for fiscal 2022 (the year ended Dec 31, 2022), against $13.3 million the year before (-17.9%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What was CHEMBIO DIAGNOSTICS, INC.'s operating income in fiscal 2022?
CHEMBIO DIAGNOSTICS, INC. reported operating income of -$23.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$31.1 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What was CHEMBIO DIAGNOSTICS, INC.'s net income in fiscal 2022?
CHEMBIO DIAGNOSTICS, INC. reported net income of -$23.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$33.9 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What was CHEMBIO DIAGNOSTICS, INC.'s cash from operating activities in fiscal 2022?
CHEMBIO DIAGNOSTICS, INC. reported cash from operating activities of -$12.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$30.9 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What are CHEMBIO DIAGNOSTICS, INC.'s total assets?
As of Dec 31, 2022, CHEMBIO DIAGNOSTICS, INC. reported total assets of $62.6 million, against $73.3 million a year earlier (-14.5%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What are CHEMBIO DIAGNOSTICS, INC.'s total liabilities?
As of Dec 31, 2022, CHEMBIO DIAGNOSTICS, INC. reported total liabilities of $44.8 million, against $39 million a year earlier (+14.9%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What are CHEMBIO DIAGNOSTICS, INC.'s cash and cash equivalents?
As of Dec 31, 2022, CHEMBIO DIAGNOSTICS, INC. reported cash and cash equivalents of $18.2 million, against $28.8 million a year earlier (-36.8%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1092662&period_type=annual&limit=5"

Information only, not investment advice.